Jiangsu Nhwa Pharmaceutical Co., Ltd.

This study tested a new medicine, NH102, for people with major depression. 243 adults took either NH102, a placebo (fake pill), or an existing antidepressant (duloxetine) for several weeks. The goal was to see if NH102 safely reduces depression symptoms better than placebo. Resul…

This early-stage study tested the safety of a new drug called NH102, which is being developed for depression. Forty healthy adults received either the drug or a placebo to check for side effects and how the drug moves through the body. The goal was not to treat depression but to …